US 10010599
Norovirus vaccine formulations
granted A61KA61K2039/5258A61K2039/54
Quick answer
US patent 10010599 (Norovirus vaccine formulations) held by Takeda Vaccines, Inc. expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Vaccines, Inc.
- Grant date
- Tue Jul 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K2039/5258, A61K2039/54, A61K2039/543, A61K2039/55572